Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.

類似資料

• Pharmacology of propranolol in patients with cirrhosis and portal hypertension.
  著者:: Arthur, M J, 等
  出版事項: (1985)
• The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension.
  著者:: Serlin, M J, 等
  出版事項: (1983)
• The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis.
  著者:: Tsai, H H, 等
  出版事項: (1989)
• The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis
  著者:: Chen, Sheng, 等
  出版事項: (2015)
• Pharmacokinetic and pharmacodynamic interactions between the ACE inhibitor cilazapril and β-adrenoceptor antagonist propranolol in healthy subjects and in hypertensive patients
  著者:: Belz, G. G., 等
  出版事項: (1989)